BIRC5 and lung cancer: Likewise, Jia et al.,[102] found that artesunate ameliorates irinotecan‐induced intestinal injury by suppressing cellular senescence and significantly enhances anti‐tumor activity, Zaho C. et al.,[33] reported that artesunate may affect metastatic tumor by regulating the expression levels of the tumor's antigens and Zhang W. et al.,[34] demonstrated suppression of lung cancer cells by downregulating the AKT/Survivin signaling pathway.